As of June 30, 2024, PharmAust Limited has 445.02M shares outstanding.
| Shares Outstanding | 445.02M |
As of June 30, 2024, PharmAust Limited maintains a current ratio of 12.42, meaning it holds 12.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.42 |
| Quick Ratio | 10.86 |
Over the twelve months ended June 30, 2024, PharmAust Limited posted a negative return on equity (ROE) of -219.94, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -88.94, reflecting losses generated across the asset base.
| Return on Equity (ROE) | -219.94 |
| Return on Assets (ROA) | -88.94 |
PharmAust Limited's most recent stock split took place on February 20, 2019 with a 500:551 split ratio.
| Last Split Date | 2/20/2019 |
| Split Ratio | 500:551 |
As of June 30, 2024, PharmAust Limited has an Altman Z-Score of -8.94, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -8.94 |
Already premium?